Despite these limitations, we reported on a novel obese NASH hamster model, in which metabolic comorbidities, a pro-inflammatory profile, altered ACE2 activity, and higher angiotensin II levels were associated with impaired recovery from a SARS-CoV-2 infection. Here, ACE2 is linked to metabolic dysfunction-associated steatohepatitis.